All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Page last updated:
1 February 2021
Invasive Group A Streptococcal infections have increased in incidence and need to be assessed rapidly in hospital. Maintain a high index of suspicion in patients with a high fever, severe muscle aches, confusion, unexplained D&V, local muscle tenderness, or severe pain out of proportion to external signs, hypotension, a flat red rash over large area of the body, conjunctival suffusion. |
The information below is based on NICE NG153 Impetigo: antimicrobial prescribing (February 2020).
Impetigo is a contagious, bacterial infection of the superficial layers of the skin. Impetigo affects all age groups; however, it is most common in young children.
Advise people with impetigo, and their parents or carers if appropriate, about good hygiene measures to reduce the spread of impetigo to other areas of the body and to other people.
Self-care advice:
Do not offer combination treatment with a topical and oral antibiotic to treat impetigo.
Consider hydrogen peroxide 1% cream for people with localised non-bullous impetigo who are not systemically unwell or at high risk of complications, if hydrogen peroxide 1% cream is unsuitable, i.e. if ineffective or if impetigo is around eyes, offer a short course of a topical antibiotic (see below for appropriate choices).
Offer a short course of a topical or oral antibiotic for people with widespread non‑bullous impetigo who are not systemically unwell or at high risk of complications (see below for appropriate choices).
Offer a short course of an oral antibiotic for all people with bullous impetigo, and people with non-bullous impetigo who are systemically unwell or at high risk of complications (see below for appropriate choices).
For people with impetigo that is worsening or has not improved after treatment with hydrogen peroxide 1% cream, offer:
For people with impetigo that is worsening or has not improved after completing a course of topical antibiotics:
For people with impetigo that is worsening or has not improved after completing a course of oral antibiotics, consider sending a skin swab for microbiological testing
For people with impetigo that recurs frequently:
If a skin swab has been sent for microbiological testing:
Reassess at any time if symptoms worsen rapidly or significantly, taking account of:
Refer to hospital:
Consider referral or seeking specialist advice for people with impetigo if they:
Consult local microbiologist if MRSA suspected or confirmed
A 5‑day course is appropriate for most people with impetigo but can be increased to 7 days based on clinical judgement, depending on the severity and number of lesions.
See section 13.11.5 Oxidisers and dyes
See section 13.10.1 Antibacterial preparations
MRSA infection in impetigo is rare, consult local microbiologist if MRSA suspected or confirmed prior to consideration of topical mupirocin
See sections 5.1.1 Penicillins and 5.1.5 Macrolides
A 5‑day course is appropriate for most people with impetigo but can be increased to 7 days based on clinical judgement, depending on the severity and number of lesions.
See section 13.11.5 Oxidisers and dyes
See section 13.10.1 Antibacterial preparations
MRSA infection in impetigo is rare, consult local microbiologist if MRSA suspected or confirmed prior to consideration of topical mupirocin
See sections 5.1.1 Penicillins and 5.1.5 Macrolides